Key Highlights

  • Standard Chartered initiated coverage of Morpho with an end-2030 price target of $60, mapping a path through $3.50 in 2026, $11 in 2027, $22 in 2028, and $40 in 2029.

  • The bank's thesis hinges on a projected 37x expansion in DeFi assets by 2030 and Morpho Vaults drawing in traditional finance capital through integrations with Fireblocks, Anchorage, and Taurus.

  • Morpho's $60 target implies roughly 2,787% upside from current levels around $2. The protocol runs at a 0% take rate, leaving all lending income to depositors, which Standard Chartered sees as a structural advantage over Aave and Uniswap.

Standard Chartered Bank initiated coverage of Morpho on Wednesday with a $60 end-2030 price target for the DeFi lending protocol's native token, a forecast the bank says would outperform both bitcoin and ether over the same period.

Geoff Kendrick, Global Head of Digital Assets Research at Standard Chartered, outlined a year-by-year price path: $3.50 by end of 2026, $11 in 2027, $22 in 2028, $40 in 2029, and $60 by end of 2030. The forecast is anchored on Morpho's position as the second-largest DeFi lending protocol after Aave, with $5.5 billion in Morpho Markets deposits and $4.3 billion across Morpho Vaults. Kendrick projects the broader DeFi sector will see a 37x increase in deployed assets by 2030.

A key element of the bull case is Morpho Vaults pulling in traditional finance capital through custody and distribution partnerships with Fireblocks, Anchorage, and Taurus. Vault curators such as Steakhouse Financial, which manages close to $2 billion in on-chain assets, have become a primary channel for institutional allocation. Standard Chartered also highlighted Morpho's 0% protocol take rate as a differentiator: unlike Aave and Uniswap, which have introduced fee mechanisms, Morpho passes all lending income directly to depositors through its vault structure. Morpho was trading around $2 at the time of the report, up nearly 13% on the day, making the $60 target approximately 2,787% above current levels.